Short Communications 6
Anxiety Disorders and Autism - Preclinical

[SC6-2] Antipsychotic agents in anxiety disorders: an umbrella review

*Rafael Freire^1,2,3, Amir Garakani^4,5, Frank Buono⁵, Mona Salehi⁶, Melissa Funaro⁷, Anna Klimowicz⁸, Harshit Sharma⁵, Clara Faria³, Kaitlyn Larkin⁹ (1. Department of Psychiatry and Centre for Neuroscience Studies, Queen's University, Kingston, Ontario, Canada, 2. Kingston General Hospital Research Institute, Kingston Health Sciences Centre, Kingston, Canada, 3. Laboratory of Panic and Respiration, Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, 4. Department of Psychiatry and Behavioral Health, Greenwich Hospital, Greenwich, CT, United States of America, 5. Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, United States of America, 6. Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America , 7. Harvey Cushing/John Hay Whitney Medical Library, Yale University, New Haven, CT, United States of America, 8. New York University Langone Psychiatry Associates, New York, NY, United States of America, 9. Department of Psychology, Northern Illinois University, DeKalb, IL, United States of America)

Keywords:generalized anxiety disorder, social anxiety disorder, antipsychotic agents, dopamine antagonist, panic disorder